Navigation Links
Scientists find gene interactions that make cocaine abuse death 8 times more likely
Date:1/22/2013

COLUMBUS, Ohio Scientists have identified genetic circumstances under which common mutations on two genes interact in the presence of cocaine to produce a nearly eight-fold increased risk of death as a result of abusing the drug.

An estimated one in three whites who died of cocaine exposure is a carrier of variants that make cocaine abuse particularly deadly.

The variants are found in two genes that affect how dopamine modulates brain activity. Dopamine is a chemical messenger vital to the regular function of the central nervous system, and cocaine is known to block transporters in the brain from absorbing dopamine after its release.

The same dopamine genes are also targeted by medications for a number of psychiatric disorders. The researchers say that these findings could help determine how patients will respond to certain drugs based on whether they, too, have mutations that interact in ways that affect dopamine flow and signaling.

The scientists had previously identified a total of seven mutations on two dopamine-related genes, some of which were linked to the risk for cocaine abuse death. Years of molecular genetics studies showed that the mutations had specific functions a single variant alone was associated with an almost three-fold increase in risk of dying of cocaine abuse and led researchers to hypothesize that the variants probably interacted because the genes themselves relied on each other for proper function.

A statistical analysis that dissected the complex interactions among the variants combined with cocaine exposure revealed gene-gene-environment interactions that would dramatically increase the risk of death from cocaine abuse.

"Finding an impact factor of 8 just blew us away," said Wolfgang Sadee, professor of pharmacology and director of the Program in Pharmacogenomics at Ohio State University and senior author of the study. "Beyond that, this represents a new paradigm. Going forward, we can ask whether such interactions do exist between variants that may be a normal variation in the population. These kinds of interactions may underlie the genetics of behavior."

These specific findings apply primarily to whites. The researchers found that a different combination of variants affect the risk of cocaine abuse death in African Americans, and that in this population, some of the variants had protective properties.

The research is published in the online journal Translational Psychiatry.

The mutations are mostly single-nucleotide polymorphisms, or SNPs (pronounced "snips"). Each gene contains two alternative forms called alleles that are functionally identical in most people. However, in some cases, the activity level, or expression, of an allele can differ from its partner allele in a single gene.

The SNPs described here are on two genes: the dopamine receptor D2, which is a target for antipsychotic drugs, and the dopamine transporter DAT, the main target of cocaine and amphetamines.

The variants' clinical relevance was determined in earlier work led by Sadee that analyzed human brain autopsy tissues of people who had died of cocaine overdose and from age-matched drug-free controls.

The variants identified in this work are harder to detect and analyze than many mutations because these variants have no role in making protein; they exist in deeper and often overlooked regions of genes. Sadee's lab has designed a technique to predict and determine their functions based on measurements of how much messenger RNA, a carrier of genetic information, each specific allele expresses.

Having a defined set of a manageable number of variables then made a statistical analysis both possible and a critical step to more fully understanding the effects of these variants. First author Danielle Sullivan, a doctoral student in biostatistics at Ohio State, built logistic regression models to search for the main effects and interactions among the variants associated with the higher risk of cocaine death.

"A combination of variants turned out to have a high effect on the risk of dying. That is called epistasis a gene-gene-environment interaction that is seen only when there is that extra stimulus, in this case the cocaine," Sadee said. "It's a three-way system, which is incredibly complex unless you know beforehand that these variables are all related to each other."

Sadee said consideration of how gene-gene-environment interactions affect the impact of single genes could help solve the mystery of "missing heritability." Scientists know that genes are behind the causes of many diseases and conditions, but to date have been unable to document the complete genetic history of any given disease.

More immediately, what he has discovered about these variants is likely to increase understanding of numerous psychiatric disorders and improve the effectiveness of medical therapies for these problems. Dopamine-related conditions include attention deficit-hyperactivity disorder, bipolar disorder, phobias, anxiety and schizophrenia.

"The gene-gene interaction that we've reported here, eliciting what might be a 'perfect dopamine storm' under cocaine stimulation, could well contribute to other conditions and affect response to drugs such as antipsychotics and amphetamines," Sadee said.

Clinical studies led by his lab so far suggest that gene-gene interactions occurring without an environmental stimulus such as cocaine do appear to help predict response to certain medications.

He is also extending the research to a handful of other genes that affect signaling in the brain.

"Each gene gives us new combinations, each one has novel variants that can be tested in this way. And they may be considered normal variations they're not associated with a disease process, but if there are multiple variants together, they may push this whole system in the direction that makes disease more likely or influences individual response to circumstances like stress or drugs," Sadee said.


'/>"/>

Contact: Wolfgang Sadee
Wolfgang.Sadee@osumc.edu
614-292-1597
Ohio State University
Source:Eurekalert

Related biology news :

1. ARS scientists test improved stink bug trapping methods
2. First in the world - Singapore scientists discover genes responsible for cornea blindness
3. Scientists seek out cancer cells hiding from treatment
4. Scientists discover structure of protein essential for quality control, nerve function
5. MBL scientists find bipolar marine bacteria, refuting everything is everywhere idea
6. 2 climate scientists win 2012 Vetlesen Prize for work on ozone hole, ice cores
7. Scientists reassemble the backbone of life with a particle accelerator
8. Scientists reassemble the backbone of life with a particle acceleratorynchrotron X-rays
9. Scripps Florida scientists uncover potential drug target to block cell death in Parkinsons disease
10. After decades of research, scientists unlock how insulin interacts with cells
11. Scientists use marine robots to detect endangered whales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
(Date:1/20/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce the attainment of ... the result of the company,s laser focus on (and ... , it,s comprehensive, easy-to-use and highly affordable cloud-based technology ... Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... January 13, 2016 ... addition of the  "India Biometrics Authentication ... Forecast (2015-2020)"  report to their ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... ... 2016 , ... Franz Inc. , an early innovator ... announced the availability of AllegroGraph 6, the leading Semantic Graph Database with certification ... Program (CCPT). AllegroGraph is the first Semantic Graph Database to be certified ...
(Date:2/8/2016)... England , February 8, 2016 ... Ltd ("Atlas Genetics" or the "Company"), the ultra-rapid Point-Of-Care (POC) ... to CE Mark its Chlamydia trachomatis (CT) test to be ... of the IVD Directive (98/79/EC), the CT test is now ... --> --> The launch of the io® ...
(Date:2/5/2016)... Feb. 5, 2016  In the pharmaceutical industry the ... host of launch activities including the identification and engagement ... activity is especially high in the oncology therapeutic area ... Practices and the Role of Medical Affairs in Oncology ... on oncology therapies find better ways to utilize medical ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf ... today announced an interactive FDA compliance training course, Writing Effective ... Professional Society) accredited interactive course on Morf Playbook—now conveniently available on smartphones and ...
Breaking Biology Technology: